Immunotherapy has become a mainstay in the treatment of non-small cell lung cancer, but more recently, it has moved into the small cell lung cancer space, too. In this episode of “The Vitals,” Beth Sandy, NP, a nurse practitioner at the University of Pennsylvania Abramson Cancer Center, discusses the immune-related adverse events (irAEs) that nurses need to be aware of when treating patients with these agents.
Sandy also discussed how some irAEs, such as difficulty breathing – which is more common in lung cancer than other tumor types – can be similar to coronavirus disease 2019 (COVID-19) symptoms. She offered advice on how to determine which it is in this unprecedented time in oncology nursing.
Talk about this article with nurses and others in the oncology community in the General Discussions
Oncology Nursing News discussion group.